oooooooooomy

[Protagonist Therapeutics @ProtagonistTx]

The FDA approval of MIMRYLO™ (rusfertide) marks the culmination of more than a decade of work at Protagonist.

Members of our team reflect on the journey and the patients, investigators, partners, and colleagues who helped make it possible.

#PTGX #FDAApproval #PV

[Carl DeMaio @carldemaio]

MILEAGE TAX ON BALLOT! CA Democrats want to charge you a new tax of 6-cents per mile you drive - costing the average driver $900 a year on top of your gas and car taxes! Your vote in November can help BLOCK this insane tax hike!
https://t.co/Aa9349GUOI

[oooooooooomy @SellThePuts]

@ProtagonistTx $ptgx 🎉🎉🎉🎉

[Protagonist Therapeutics @ProtagonistTx]

China’s drug regulator has approved #ICOTYDE for moderate-to-severe plaque psoriasis.

ICOTYDE continues to demonstrate the power of our peptide discovery platform and long-term collaboration with Johnson & Johnson. With approvals now in the U.S. and China, we look forward to the European Commission’s decision and the potential to bring this differentiated oral therapy to more patients globally.

https://t.co/0BqEMv7KyT

#Psoriasis #IL23 #OralPeptides

[Dr J Rould @jrouldz]

haven't been buying megacaps lately but $AVGO looks tempting

[Shay Boloor @StockSavvyShay]

OpenAI says its new Jalapeno chip built with $AVGO beat $NVDA Blackwell on two of the most important inference metrics.

Jalapeno reportedly delivered more AI work per watt and faster response times as inference becomes a larger share of AI compute.

[Dinesh V. Patel, PhD @ProtagonistCEO]

It was great to join @SchwabNetwork last Friday. Thanks to the Schwab team for having me, and to the entire @ProtagonistTx team whose non-stop hard work continues to move our company forward and advance new medicines for patients.

[oooooooooomy @SellThePuts]

@ProtagonistCEO @SchwabNetwork @ProtagonistTx Great job @ProtagonistCEO! $PTGX

[oooooooooomy @SellThePuts]

@ProtagonistTx @GalienFdn 🔥🔥🔥🔥

[Protagonist Therapeutics @ProtagonistTx]

Today, ICOTYDE™ was nominated for the 2026 #PrixGalien USA Award for Best Pharmaceutical Product.

This recognition by @GalienFdn highlights the scientific innovation behind the first and only FDA-approved targeted oral peptide designed to block the IL-23 receptor, bringing a novel plaque psoriasis treatment approach that combines the established efficacy and safety of IL-23 pathway blockade with the convenience of a once-daily oral pill.

We’re gratified to see an innovation that began at Protagonist being recognized among this year's nominees and congratulate our colleagues at Johnson & Johnson, the Protagonist team, clinical investigators, and the patients who helped make this possible.

#PeptideTherapeutics #DrugDiscovery #Innovation

https://t.co/1NMC1pkQzq

[Protagonist Therapeutics @ProtagonistTx]

On Friday, @ProtagonistCEO Dinesh Patel joined @SchwabNetwork #NextGenInvesting live to discuss peptides, obesity, and biopharma disruption.

Watch it here: https://t.co/vl1RQlPY6Q

#schwabnetwork

[Protagonist Therapeutics @ProtagonistTx]

Catch CEO Dinesh Patel today live on Schwab Network around 1:35 ET!

https://t.co/CY5cJJhP9e

#PTGX #SchwabNetwork #NextGenInvesting

[oooooooooomy @SellThePuts]

@ProtagonistTx Great job, Dinesh!

[oooooooooomy @SellThePuts]

@ProtagonistTx @ProtagonistCEO @SchwabNetwork 🔥🔥🔥🔥🔥

[Steve Hilton @SteveHiltonx]

16 years of one-party rule. Highest costs, highest poverty, businesses fleeing every day.

The polls are tightening fast and this could be the big upset of 2026.

Wake Up California!

[oooooooooomy @SellThePuts]

@elonmusk Need a high end model

[oooooooooomy @SellThePuts]

@AGCypher @MPelletierCIO I thought the $6.5m is revenue. I don’t believe he said $6.5m profit.

[Shay Boloor @StockSavvyShay]

J.P. Morgan says the market is ignoring 12 years of $AVGO execution at $GOOGL and would be “aggressive buyers at current levels.”

The 5-year Google deal still locks Broadcom into TPU v8-v11 with rising revenue commitments while $META, $AAPL, OpenAI, Anthropic, ByteDance and SoftBank programs remain on track.

J.P. Morgan sees over $56B of AI revenue in FY26 and another 2x to 2.5x growth in FY27 with Tomahawk 6 already sold out through next year and Samsung supply commitments implying $1T of cumulative AI revenue over 5 years.

[Jim Rowe @jimrowe77268]

@NateSilver538 Reminder Silver said Hong would win by 20% she lost.

He knows dick

[oooooooooomy @SellThePuts]

@Carnageinwild AI as fuck